Mesa Laboratories, Inc. (MLAB) - NASDAQ
  • Thu, Jun. 2, 12:45 PM
    | Thu, Jun. 2, 12:45 PM
  • Thu, Jun. 2, 8:38 AM
    • Mesa Laboratories (MLAB) FQ4 results: Revenues: $24.8M (+33.3%); Operating Expense: $9.2M (+26.0%); Operating Income: $5.8M (+38.1%); Net Income: $4M (+81.8%); EPS: $1.06 (+73.8%); Non-GAAP EPS: $1.33 (+66.3%).
    • FY2016 results: Revenues: $84.7M (+18.8%); Operating Expense: $35.1M (+27.6%); Operating Income: $16.3M (+2.5%); Net Income: $11.2M (+16.7%); EPS: $2.97 (+12.9%); Non-GAAP EPS: $4.08 (+19.0%); Quick Assets: $5.7M (+185.0%).
    • No guidance given.
    | Thu, Jun. 2, 8:38 AM
  • Thu, Jun. 2, 8:13 AM
    • Mesa Laboratories (NASDAQ:MLAB): FQ4 EPS of $1.33 beats by $0.39.
    • Revenue of $24.81M (+33.7% Y/Y) beats by $2.95M.
    • Press Release
    | Thu, Jun. 2, 8:13 AM
  • Tue, Apr. 12, 2:19 PM
    • Mesa Laboratories (NASDAQ:MLAB) declares $0.16/share quarterly dividend, in line with previous.
    • Forward yield 0.66%
    • Payable June 15; for shareholders of record May 31; ex-div May 26.
    | Tue, Apr. 12, 2:19 PM
  • Tue, Feb. 2, 9:39 AM
    • Mesa Laboratories (MLAB -3.1%) FQ3 results: Revenues: $19.9M (+11.8%); Operating Expense: $8.4M (+15.1%); Operating Income: $3.8M (+2.7%); Net Income: $2.4M (-1.7%); EPS: $0.63 (-4.5%); Non-GAAP EPS: $0.92 (+5.7%); Quick Assets: $3.3M (+65.0%).
    • No guidance given.
    | Tue, Feb. 2, 9:39 AM
  • Tue, Feb. 2, 8:07 AM
    • Mesa Laboratories (NASDAQ:MLAB): FQ3 EPS of $0.92 misses by $0.03.
    • Revenue of $19.91M (+11.7% Y/Y) misses by $2.14M.
    • Press Release
    | Tue, Feb. 2, 8:07 AM
  • Tue, Jan. 5, 2:02 PM
    • Mesa Laboratories (NASDAQ:MLAB) declares $0.16/share quarterly dividend, in line with previous.
    • Forward yield 0.64%
    • Payable March 15; for shareholders of record Feb. 29; ex-div Feb. 25.
    | Tue, Jan. 5, 2:02 PM
  • Nov. 2, 2015, 8:43 AM
    • Mesa Laboratories (MLAB) FQ2 results: Revenues: $21.8M (+17.8%); COGS: $8.7M (+17.6%); Operating Expense: $10.1M (+62.9%); Operating Income: $3M (-38.8%); Net Income: $1.8M (-41.9%); EPS: $0.47 (-44.0%); Quick Assets: $5.5M (+175.0%).
    • No guidance given.
    | Nov. 2, 2015, 8:43 AM
  • Nov. 2, 2015, 8:13 AM
    • Mesa Laboratories (NASDAQ:MLAB): FQ2 EPS of $0.72 misses by $0.31.
    • Revenue of $21.76M (+17.6% Y/Y) misses by $0.54M.
    | Nov. 2, 2015, 8:13 AM
  • Oct. 2, 2015, 9:06 AM
    • Mesa Laboratories (NASDAQ:MLAB) declares $0.16/share quarterly dividend, in line with previous.
    • Forward yield 0.56%
    • Payable Dec. 15; for shareholders of record Nov. 30; ex-div Nov. 25.
    | Oct. 2, 2015, 9:06 AM
  • Aug. 6, 2015, 11:00 AM
    • Mesa Laboratories (MLAB -1%) acquires the dental sterilizer business of North Bay Bioscience for $11.25M. The deal will add $4M to Mesa's top line and will be accretive to earning during the first 12 months. The bulk of the business involves the testing of small counter-top sterilizers located in dental offices.
    | Aug. 6, 2015, 11:00 AM
  • Aug. 3, 2015, 8:45 AM
    • Mesa Laboratories (MLAB +3.2%) Q2 results: Revenues: $18.2M (+11.0%); COGS: $7M (+4.5%); Operating Expenses: $7.5M (+11.9%); Operating Income: $3.6M (+16.1%); Net Income: $2.3M (+21.1%); EPS: $0.63 (+23.5%); Quick Assets: $1.97M (-3.0%).
    • No guidance given.
    | Aug. 3, 2015, 8:45 AM
  • Aug. 3, 2015, 8:04 AM
    • Mesa Laboratories (NASDAQ:MLAB): Q2 EPS of $0.85 beats by $0.02.
    • Revenue of $18.16M (+10.7% Y/Y) misses by $18.76B.
    | Aug. 3, 2015, 8:04 AM | 1 Comment
  • Jul. 8, 2015, 11:32 AM
    • Mesa Laboratories (NASDAQ:MLAB) declares $0.16/share quarterly dividend, in line with previous.
    • Forward yield 0.72%
    • Payable Sept. 15; for shareholders of record Aug. 31; ex-div Aug. 27.
    | Jul. 8, 2015, 11:32 AM
  • Jul. 6, 2015, 12:51 PM
    • Mesa Laboratories (MLAB -1.8%) acquires Markham, Ontario-based Infitrak for $12M CDN ($9.6M USD) plus a future contingent payment of up to $15M CDN ($12M USD). The deal will add ~$5.5M to Mesa's top line and will be accretive to earnings during the first 12 months.
    • Infitrak focuses on "cold chain" services, a supply chain for temperature-sensitive products that provides an uninterrupted series of storage and distribution activities within a certain temperature range. Cold chains are used primarily in the pharmaceutical, healthcare and food industries.
    | Jul. 6, 2015, 12:51 PM | 3 Comments
  • Jun. 1, 2015, 9:32 AM
    • Mesa Laboratories (MLAB) FQ4 results: Revenues: $18.6M (+18.5%); COGS: $7M (+14.8%); Operating Expenses: $7.3M (+17.7%); Operating Income: $4.2M (+23.5%); Net Income: $2.2M (-37.1%); EPS: $0.61 (-35.8%).
    • FY2015 results: Revenues: $71.3M (+35.3%); COGS: $27.9M (+32.9%); Operating Expenses: $27.5M (+38.2%); Operating Income: $15.9M (+33.6%); Net Income: $9.6M (+6.7%); EPS: $2.63 (+5.6%); Quick Assets: $2M (-64.3%).
    • No guidance given.
    | Jun. 1, 2015, 9:32 AM
Company Description
Mesa Laboratories, Inc. designs, manufactures, and markets instruments and disposable products utilized primarily in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Biological Indicators, Instruments,... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States